We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Organic growth amounted to 3.9%, of which volume accounted for 1.7% and price/mix 2.2%. Excluding restructuring, organic growth increased 4.9%.EBITA decreased 1% to SEK ...

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

Phase II trial evaluating efti in combination with radiotherapy plus KEYTRUDA® (pembrolizumab) in patients with soft tissue sarcoma reaches ...

If not for maple syrup, March in Vermont would be all about mud season. Thank goodness that the grey days and muddy roads of ...

A study published in Nature Medicine looks at the health risks and benefits linked to GLP-1 receptor agonists. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University ...

The president moved swiftly in his first hours in office, signing a slew of executive orders in front of a roaring crowd and ...

Kash Patel, Donald J. Trump’s choice to run the bureau, has made a series of spurious assertions about the Russia, Jan. 6 and ...

whilst “American” Merck (now Merck & Co. in the US or Merck Sharp & Dohme (MSD) elsewhere) was compulsorily split off from its Germany parent company (Merck KGaA) at the same time. Bayer also ...

Buoyed by strong earnings and AI investment news, markets rallied. Oracle spiked 7.5% while Apple and Walgreens dragged with sharp declines. Mixed global reactions to new tariffs announced by ...

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...